SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers
Jie Mei(Sun Yat-sen University), Yongmei Yin(Jiangsu Cancer Hospital), Yichao Zhu(Nanjing Medical University), Junying Xu(Wuxi People's Hospital), Ziyi Fu, Chenghu Song(Wuxi People's Hospital), Jiaofeng Zhou(Harbin Medical University), Yun Cai, Wenjun Mao(Wuxi People's Hospital)
Cited by 1
Related Papers
The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
|Journal of Neuroinflammation|2018|268
The role of lipid metabolic reprogramming in tumor microenvironment
|Theranostics|2023|223
Dvl2-Dependent Activation of Daam1 and RhoA Regulates Wnt5a-Induced Breast Cancer Cell Migration
|PLoS ONE|2012|123